NovaBay Pharmaceuticals, Inc.
Market Cap
$50.06M
P/E Ratio
-0.07
EPS
$-28.50
Dividend Yield
0.00%
52-Week Range
$1.11 — $99.75
Volume
317.16K
Avg Volume
552.07K
Beta
0.16
Get alerted when NBY hits your target price.
Free — enter your email to get started
P/E (TTM)
-0.07
Forward P/E
—
PEG Ratio
-0.01
P/S (TTM)
0.00
P/B (TTM)
-0.41
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
12.37%
ROA (TTM)
-3.13%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
-0.03
Current Ratio
7.39
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.22%
EPS Growth (5Y)
+0.31%
Sales Growth (3Y)
+0.02%
Sales Growth (5Y)
+0.12%
EPS Est (This Year)
$-0.38
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
$0.80
Payout Ratio
—
Frequency
—
Ex-Dividend Date
2025-09-30
Cash/Share
$1.37
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
126.17M
Float
124.97M
Free Float %
99.04%
RSI (14)
0.31
SMA 20
$4.69
SMA 50
$4.77
SMA 200
$2.19
ATR (14)
0.56
Volatility (Week)
0.13%
Volatility (Month)
0.29%
Pattern
Shooting Star
1 Day
-5.05%
1 Week
-39.65%
1 Month
-96.35%
3 Months
-33.95%
6 Months
+16.68%
1 Year
—
YTD
-88.07%
All-Time High
$19.95
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
AMEX
IPO Date
2007-10-26
Employees
13
CEO
Michael Kazley
Index Membership
—
Website
https://novabay.com
NovaBay Pharmaceuticals, Inc. (NBY) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $50.06M, a P/E ratio of -0.07, NBY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NBY against other stocks using dozens of fundamental and technical filters.
NovaBay Pharmaceuticals, Inc. (NBY) has a trailing twelve-month (TTM) P/E ratio of -0.07. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, NovaBay Pharmaceuticals, Inc. (NBY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
NovaBay Pharmaceuticals, Inc. (NBY) has a market capitalization of $50.06 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
NovaBay Pharmaceuticals, Inc. (NBY) has returned -88.07% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.